AAAAAA

   
Results: 1-8 |
Results: 8

Authors: SVARE EI KJAER SK NONNENMACHER B WORM AM MOI H CHRISTENSEN RB VANDENBRULE AJC WALBOOMERS JMM MEIJER CJLM HUBBERT NL LOWY DR SCHILLER JT
Citation: Ei. Svare et al., SEROREACTIVITY TO HUMAN-PAPILLOMAVIRUS TYPE-16 VIRUS-LIKE PARTICLES IS LOWER IN HIGH-RISK MEN THAN IN HIGH-RISK WOMEN, The Journal of infectious diseases, 176(4), 1997, pp. 876-883

Authors: WIDEROFF L SCHIFFMAN MH HOOVER R TARONE RE NONNENMACHER B HUBBERT N KIRNBAUER R GREER CE LORINCZ AT MANOS MM GLASS AG SCOTT DR SHERMAN ME BUCKLAND J LOWY D SCHILLER J
Citation: L. Wideroff et al., EPIDEMIOLOGIC DETERMINANTS OF SEROREACTIVITY TO HUMAN PAPILLOMAVIRUS (HPV) TYPE-16 VIRUS-LIKE PARTICLES IN CERVICAL HPV-16 DNA-POSITIVE ANDDNA-NEGATIVE WOMEN, The Journal of infectious diseases, 174(5), 1996, pp. 937-943

Authors: NONNENMACHER B KJAER SK SVARE EI SCOTT JD HUBBERT NL VANDENBRULE AJC KIRNBAUER R WALBOOMERS JMM LOWY DR SCHILLER JT
Citation: B. Nonnenmacher et al., SEROREACTIVITY TO HPV16 VIRUS-LIKE PARTICLES AS A MARKER FOR CERVICAL-CANCER RISK IN HIGH-RISK POPULATIONS, International journal of cancer, 68(6), 1996, pp. 704-709

Authors: BREITBURD F KIRNBAUER R HUBBERT NL NONNENMACHER B TRINDINHDESMARQUET C ORTH G SCHILLER JT LOWY DR
Citation: F. Breitburd et al., IMMUNIZATION WITH VIRUS-LIKE PARTICLES FROM COTTONTAIL RABBIT PAPILLOMAVIRUS (CRPV) CAN PROTECT AGAINST EXPERIMENTAL CRPV INFECTION, Journal of virology, 69(6), 1995, pp. 3959-3963

Authors: WIDEROFF L SCHIFFMAN MH NONNENMACHER B HUBBERT N KIRNBAUER R GREER CE LOWY D LORINCZ AT MANOS MM GLASS AG SCOTT DR SHERMAN ME KURMAN RJ BUCKLAND J TARONE RE SCHILLER J
Citation: L. Wideroff et al., EVALUATION OF SEROREACTIVITY TO HUMAN PAPILLOMAVIRUS TYPE-16 VIRUS-LIKE PARTICLES IN AN INCIDENT CASE-CONTROL STUDY OF CERVICAL NEOPLASIA, The Journal of infectious diseases, 172(6), 1995, pp. 1425-1430

Authors: NONNENMACHER B HUBBERT NL KIRNBAUER R SHAH KV MUNOZ N BOSCH FX DESANJOSE S VISCIDI R LOWY DR SCHILLER JT
Citation: B. Nonnenmacher et al., SEROLOGIC RESPONSE TO HUMAN PAPILLOMAVIRUS TYPE-16 (HPV-16) VIRUS-LIKE PARTICLES IN HPV-16 DNA-POSITIVE INVASIVE CERVICAL-CANCER AND CERVICAL INTRAEPITHELIAL NEOPLASIA GRADE-III PATIENTS AND CONTROLS FROM COLOMBIA AND SPAIN, The Journal of infectious diseases, 172(1), 1995, pp. 19-24

Authors: KIRNBAUER R NONNENMACHER B HUBBERT N SHAH K MUNOZ N SCHIFFMANN M BOSCH X VISCIDI R LOWY D SCHILLER J
Citation: R. Kirnbauer et al., SEROLOGIC RESPONSE TO HPV16 CAPSIDS IN WOMEN IS ASSOCIATED WITH PERSISTENT HPV16 INFECTION AND INCREASED CERVICAL-CANCER RISK, Journal of investigative dermatology, 103(3), 1994, pp. 436-436

Authors: KIRNBAUER R HUBBERT NL NONNENMACHER B LOWY DR SCHILLER JT ORTH G BREITBURD F
Citation: R. Kirnbauer et al., A VACCINE OF VIRUS-LIKE PARTICLES MADE IN INSECT CELLS CAN INHIBIT PAPILLOMAVIRUS INFECTION OF RABBITS, Journal of investigative dermatology, 102(4), 1994, pp. 542-542
Risultati: 1-8 |